DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Risperdal (Risperidone) - Published Studies

 
 



Risperdal Related Published Studies

Well-designed clinical trials related to Risperdal (Risperidone)

Double-blind, placebo-controlled trial of risperidone plus amantadine in children with autism: a 10-week randomized study. [2013]

Memantine add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized, double-blind, placebo-controlled study. [2013]

Risperidone dosing in children and adolescents with autistic disorder: a double-blind, placebo-controlled study. [2013]

Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial. [2013]

Characteristics of responders and non-responders to risperidone monotherapy or placebo in co-occurring bipolar disorder and anxiety disorder. [2013]

Efficacy of risperidone in children with disruptive behavioural disorders. [2013]

Double-blind placebo-controlled randomized efficacy and safety trial of add-on treatment of dimebon plus risperidone in schizophrenic patients during transition from acute psychotic episode to remission. [2012]

Cost and cost-effectiveness in a randomized trial of long-acting risperidone for schizophrenia. [2012]

Early treatment with risperidone for subsyndromal delirium after on-pump cardiac surgery in the elderly: a randomized trial. [2012]

A double-blind placebo controlled trial of Ginkgo biloba added to risperidone in patients with autistic disorders. [2012]

Therapeutic effects of cerebrolysin added to risperidone in patients with schizophrenia dominated by negative symptoms. [2012]

Effects of risperidone and haloperidol on superoxide dismutase and nitric oxide in schizophrenia. [2012]

Risperidone and olanzapine versus another first generation antipsychotic in patients with schizophrenia inadequately responsive to first generation antipsychotics. [2012]

A placebo-controlled study of the modafinil added to risperidone in chronic schizophrenia. [2012]

Co-morbid Disruptive Behavior Disorder and Aggression Predict Functional Outcomes and Differential Response to Risperidone Versus Divalproex in Pharmacotherapy for Pediatric Bipolar Disorder. [2011.12.02]

A placebo-controlled study of the modafinil added to risperidone in chronic schizophrenia. [2011.09.24]

A double-blind, placebo-controlled study of risperidone for the treatment of adolescents and young adults with anorexia nervosa: a pilot study. [2011.09]

A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP). [2011.09]

Olanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes. [2011.08.15]

Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial. [2011.08.03]

A double-blind, placebo-controlled study of traditional Chinese medicine sarsasapogenin added to risperidone in patients with negative symptoms dominated schizophrenia. [2011.08]

Impact of olanzapine or risperidone treatment on insulin sensitivity in schizophrenia or schizoaffective disorder. [2011.08]

Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder: fMRI outcomes. [2011.07.30]

A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia. [2011.06.01]

Comparative pharmacokinetics and bioequivalence of two tablet formulations of 2 mg risperidone in healthy Thai male volunteers. [2011.06]

Weight changes and their associations with demographic and clinical characteristics in risperidone maintenance treatment for schizophrenia. [2011.06]

An open-label trial of risperidone in children and adolescents with severe mood dysregulation. [2011.06]

Effectiveness of haloperidol, risperidone and olanzapine in the treatment of first-episode non-affective psychosis: results of a randomized, flexible-dose, open-label 1-year follow-up comparison. [2011.06]

Central nervous system effects of the interaction between risperidone (single dose) and the 5-HT6 antagonist SB742457 (repeated doses) in healthy men. [2011.06]

Metabolic parameters in the short- and long-term treatment of schizophrenia with sertindole or risperidone. [2011.06]

Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: Comparing treatment with risperidone and haloperidol. [2011.05.13]

An open randomized pilot trial on the differential effects of aripiprazole versus risperidone on anhedonia and subjective well-being. [2011.05]

Difference in early prediction of antipsychotic non-response between risperidone and olanzapine in the treatment of acute-phase schizophrenia. [2011.05]

Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimer's disease: a randomized double-blind pilot study. [2011.04.15]

Long-acting risperidone and oral antipsychotics in unstable schizophrenia. [2011.03.03]

Olanzapine vs. risperidone in treating aggressive behaviours in adults with intellectual disability: a single blind study. [2011.02]

Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial. [2011.02]

Galantamine augmentation of long-acting injectable risperidone for cognitive impairments in chronic schizophrenia. [2011.02]

Mirtazapine augmentation enhances cognitive and reduces negative symptoms in schizophrenia patients treated with risperidone: a randomized controlled trial. [2011.01.15]

A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia. [2011.01.15]

Co-morbid disruptive behavior disorder and aggression predict functional outcomes and differential response to risperidone versus divalproex in pharmacotherapy for pediatric bipolar disorder. [2011]

A double-blind, placebo-controlled study of risperidone for the treatment of adolescents and young adults with anorexia nervosa: a pilot study. [2011]

A pilot study of the efficacy and safety of paroxetine augmented with risperidone, valproate, buspirone, trazodone, or thyroid hormone in adult Chinese patients with treatment-resistant major depression. [2011]

Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial. [2011]

A double-blind, placebo-controlled study of traditional Chinese medicine sarsasapogenin added to risperidone in patients with negative symptoms dominated schizophrenia. [2011]

Long acting injection versus oral risperidone in first-episode schizophrenia: differential impact on white matter myelination trajectory. [2011]

Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder: fMRI outcomes. [2011]

A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia. [2011]

Mirtazapine augmentation enhances cognitive and reduces negative symptoms in schizophrenia patients treated with risperidone: a randomized controlled trial. [2011]

A double-blind, randomized study comparing the efficacy and safety of sertindole and risperidone in patients with treatment-resistant schizophrenia. [2011]

Association of 9-hydroxy risperidone concentrations with risk of switching or discontinuation in the clinical antipsychotic trial of intervention effectiveness-Alzheimer's disease trial. [2010.12]

A double-blind, randomized, and placebo-controlled trial of buspirone added to risperidone in patients with chronic schizophrenia. [2010.12]

Suicide attempts in a prospective cohort of patients with schizophrenia treated with sertindole or risperidone. [2010.12]

Relative bioavailability of two oral formulations of risperidone 2 mg: A single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Brazilian volunteers. [2010.11]

Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder. [2010.10.01]

Esquire trial: efficacy and adverse effects of quetiapine versus risperidone in first-episode schizophrenia. [2010.10]

Adjunctive risperidone for partially responsive people with schizophrenia treated with clozapine. [2010.10]

Comparison of olanzapine and risperidone in the EMBLEM Study: translation of randomized controlled trial findings into clinical practice. [2010.09]

Relative bioavailability and pharmacokinetic comparison of two 2-mg risperidone tablet formulations: A single dose, randomized-sequence, double-blind, 2-way crossover study in healthy male volunteers in Thailand. [2010.09]

Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder. [2010.09]

Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial. [2010.08.04]

A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia. [2010.07]

Risperidone versus olanzapine for the treatment of delirium. [2010.06]

Risperidone maintenance treatment in schizophrenia: a randomized, controlled trial. [2010.06]

Medication satisfaction in schizophrenia: a blinded-initiation study of paliperidone extended release in patients suboptimally responsive to risperidone. [2010.05]

A randomized controlled trial of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced tardive dyskinesia. [2010.04.20]

Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone. [2010.03.24]

Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism. [2010.02.01]

Comparison of topiramate and risperidone for the treatment of behavioral disturbances of patients with Alzheimer disease: a double-blind, randomized clinical trial. [2010.02]

The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: a double-blind randomized placebo-controlled trial. [2010.02]

Clinical overview of children with mucopolysaccharidosis type III A and effect of Risperidone treatment on children and their mothers psychological status. [2010.02]

Serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms. [2010.01]

A trial of quetiapine compared with risperidone in the treatment of first onset psychosis among 15- to 18-year-old adolescents. [2010.01]

Association of 9-hydroxy risperidone concentrations with risk of switching or discontinuation in the clinical antipsychotic trial of intervention effectiveness-Alzheimer's disease trial. [2010]

A double-blind, randomized, and placebo-controlled trial of buspirone added to risperidone in patients with chronic schizophrenia. [2010]

A randomized, double-blind comparison of risperidone versus low-dose risperidone plus low-dose haloperidol in treating schizophrenia. [2010]

Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder. [2010]

Comparison of risperidone orodispersible tablet and intramuscular haloperidol in the treatment of acute psychotic agitation: a randomized open, prospective study. [2010]

Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorder. [2010]

Comparison of topiramate and risperidone for the treatment of behavioral disturbances of patients with Alzheimer disease: a double-blind, randomized clinical trial. [2010]

The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: a double-blind randomized placebo-controlled trial. [2010]

Cognitive function with long-term risperidone in children and adolescents with disruptive behavior disorder. [2009.12]

A 6-week, randomized, double-blind, placebo-controlled study of the efficacy and safety of risperidone in adolescents with schizophrenia. [2009.12]

A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently. [2009.12]

Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study. [2009.11]

Effects of olanzapine and risperidone on glucose metabolism and insulin sensitivity in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized 5-month study. [2009.11]

Effect of Warm-Supplementing Kidney Yang (WSKY) added to risperidone on quality of life in patients with schizophrenia: a randomized controlled trial. [2009.11]

A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome. [2009.10]

A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy. [2009.10]

Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia. [2009.10]

Effect of Warm-Supplementing Kidney Yang (WSKY) added to risperidone on quality of life in patients with schizophrenia: a randomized controlled trial. [2009.09.28]

Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study. [2009.06]

Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR). [2009.06]

Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety. [2009.06]

A comparison of low-dose risperidone to paroxetine in the treatment of panic attacks: a randomized, single-blind study. [2009.05.26]

Switching to aripiprazole in outpatients with schizophrenia experiencing insufficient efficacy and/or safety/tolerability issues with risperidone: a randomized, multicentre, open-label study. [2009.05]

Cognitive effectiveness of olanzapine and risperidone in first-episode psychosis. [2009.05]

Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison. [2009.05]

Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial. [2009.05]

Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison. [2009.04.21]

A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone. [2009.04]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014